Your browser doesn't support javascript.
loading
T cell immune awakening in response to immunotherapy is age-dependent.
Salih, Zena; Banyard, Antonia; Tweedy, Joshua; Galvani, Elena; Middlehurst, Philippa; Mills, Sarah; Weightman, John; Gupta, Avinash; Lorigan, Paul C; Zhou, Cong; Dhomen, Nathalie; Valpione, Sara; Marais, Richard.
Afiliação
  • Salih Z; Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom; The Christie NHS Foundation Trust, 550 Wilmslow Road, Manchester M20 4BX, United Kingdom.
  • Banyard A; Flow Cytometry, Cancer Research UK Manchester Institute, the University of Manchester, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom.
  • Tweedy J; Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom.
  • Galvani E; Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom.
  • Middlehurst P; Manchester Cancer Research Centre Biobank, The Christie NHS Foundation Trust, 550 Wilmslow Road, Manchester M20 4BX, United Kingdom.
  • Mills S; Manchester Cancer Research Centre Biobank, The Christie NHS Foundation Trust, 550 Wilmslow Road, Manchester M20 4BX, United Kingdom.
  • Weightman J; Molecular Biology Core Facility, Cancer Research UK Manchester Institute, the University of Manchester, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom.
  • Gupta A; The Christie NHS Foundation Trust, 550 Wilmslow Road, Manchester M20 4BX, United Kingdom.
  • Lorigan PC; The Christie NHS Foundation Trust, 550 Wilmslow Road, Manchester M20 4BX, United Kingdom; Division of Cancer Sciences, The University of Manchester, Oxford Road, Manchester M13 9PL, United Kingdom.
  • Zhou C; Cancer Biomarker Centre, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom.
  • Dhomen N; Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom.
  • Valpione S; Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom; The Christie NHS Foundation Trust, 550 Wilmslow Road, Manchester M20 4BX, United Kingdom.
  • Marais R; Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom. Electronic address: richard.marais@cruk.manchester.ac.uk.
Eur J Cancer ; 162: 11-21, 2022 02.
Article em En | MEDLINE | ID: mdl-34952479
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Melanoma Tipo de estudo: Prognostic_studies Limite: Aged / Humans / Newborn Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Melanoma Tipo de estudo: Prognostic_studies Limite: Aged / Humans / Newborn Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido